Biomedical Engineering Reference
In-Depth Information
13. Xu, H.; Aguilar, Z.; Wang, A. Quantum Dot-based Sensors for Proteins.
ECS Trans.
2010,
25,
1-10.
14. Pusic, K.; Xu, H.; Stridiron, A.; Aguilar, Z.; Wang, A. Z.; Hui, H. Blood Stage Merozoite
Surface Protein Conjugated to Nanoparticles Induce Potent Parasite Inhibitory Antibodies.
Vaccine
2011,
29,
8898-8908.
15. Xu, H.; Aguilar, Z. P.; Yang, L.; Kuang, M.; Duan, H.; Xiong, Y.; Wei, H.; Wang, A. Y. Anti-
body Conjugated Magnetic Iron Oxide Nanoparticles for Cancer Cell Separation in Fresh
Whole Blood.
Biomaterials
2011,
32,
9758-9765.
16. Yang, L.; Cao, Z.; Sajja, H.; Mao, H.; Wang, L.; Geng, H.; Xu, H.; Jiang, T.; Wood, W.; Nie, S.;
Wang, A. Development of Receptor Targeted Iron Oxide Nanoparticles for Efficient Drug Deliv-
ery and Tumor Imaging.
J. Biomed. Nanotech.
2008,
4,
1-11.
17. Yang, L.; Peng, X.; Wang, Y.; Wang, X.; Cao, Z.; Ni, C.; Karna, P.; Zhang, X.; Wood, W.;
Gao, X.; Nie, S.; Mao, H. Receptor-targeted Nanoparticles for In vivo Imaging of Breast
Cancer.
Clin. Cancer Res.
2009,
15,
4722-4732.
18. Jin, S.; Ye, K. Nanoparticle-mediated Drug Delivery and Gene Therapy.
Biotechnol. Prog.
2007,
23,
32-41.
19. Kamps, J. A.; Scherphof, G. L. Receptor versus Non-receptor Mediated Clearance of Lipo-
somes.
Adv. Drug Deliv. Rev.
1998,
32,
81-97.
20. Moghimi, S. M.; Szebeni, J. Stealth Liposomes and Long Circulating Nanoparticles: Critical
Issues in Pharmacokinetics, Opsonization and Protein-binding Properties.
Prog. Lipid. Res.
2003,
42,
463-478.
21. Morgen, M.; Lu, G. W.; Dub, D.; Stehle, R.; Lembke, F.; Cervantes, J.; Ciotti, S.; Haskell, R.;
Smithey, D.; Haley, K.; Fan, C. Targeted Delivery of a Poorly Water-soluble Compound to
Hair Follicles Using Polymeric Nanoparticle Suspensions.
Int. J. Pharm.
2011,
416,
314-322.
22. Pastorino, F.; Brignole, C.; Marimpietri, D.; Sapra, P.; Moase, E. H.; Allen, T. M.; Ponzoni,
M. Doxorubicin-loaded Fab' Fragments of Anti-disialoganglioside Immunoliposomes Selec-
tively Inhibit the Growth and Dissemination of Human Neuroblastoma in Nude Mice.
Cancer
Res.
2003,
63,
86-92.
23. Tiwari, S. B.; Amiji, M. M. A Review of Nanocarrier-based CNS Delivery Systems.
Curr.
Drug Del.
2006,
3,
219-232.
24. Tobio, M.; Sanchez, A.; Vila, A.; Soriano, I.; Evora, C.; Vila-Jato, J. L.; Alonso, M. J. Inves-
tigation of Lectin-modified Insulin Liposomes as Carriers for Oral Administration.
Colloids
Surf. B
2000,
18,
315-323.
25. Torchilin, V. P.; Shtilman, M. I.; Trubetskoy, V. S.; Whiteman, K.; Milstein, A. M. Amphiphilic
Vinyl Polymers Effectively Prolong Liposome Circulation Time In vivo.
Biochim. Biophys.
Acta
1994,
1195,
181-184.
26. Zhang, N.; Ping, Q. N.; Huang, G. H.; Xu, W. F. Investigation of Lectin-Modified Insulin
Liposomes as Carriers for Oral Administration.
Int. J. Pharm.
2005,
294,
247-259.
27. Topoglidis, E. A.; Cass, E., et al. Protein Adsorption on Nanocrystalline TiO
2
Films: An
Immobilization Strategy for Bioanalytical Devices.
Anal. Chem.
1998,
70,
5111-5113.
28. Connor, E. E.; Mwamuka, J.; Gole, A.; Murphy, C. J.; Wyatt, M. D. Gold Nanoparticles are
Taken Up by Human Cells but do not Cause Acute Cytotoxicity.
Small
2005,
1,
325.
29. Xu, H.; Qu, F.; Xu, H.; Lai, W.; Wang, Y. A.; Aguilar, Z. P.; Wei, H. Role of Reactive Oxygen
Species in the Antibacterial Mechanism of Silver Nanoparticles on
E. coli
O157:H7.
Biometals
2012,
25,
45-53.
30. Loeschner, K.; Hadrup, N.; Qvotrup, K.; Larsen, A.; Gao, X.; Vogel, U.; Mortensen, A.;
Lam, H. R.; Larsen, E. H. Distribution of Silver in Rats Following 28 Days of Repeated Oral
Exposure to Silver Nanoparticles or Silver Acetate.
Part. Fibre Toxicol.
2011,
8,
18.
